Corticotropin
/api/v1/drug/corticotropinMechanism of action
Sourced from openFDAMechanism-of-action class: Pituitary Hormone Receptor Agonists.
Indications
Sourced from openFDA- USES TAKE 15 MINUTES BEFORE MEALS
Dosage & administration
Sourced from openFDADIRECTIONS Take 15 minutes before meals Adults : 20 drops in a little water, 2 times per day
Warnings & precautions
Sourced from openFDAStop use and ask doctor if symptoms persist more than 5 days. If pregnant or breast-feeding ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. Contains ethyl alcohol 30%
Approval history
Sourced from openFDA- Apr 29, 1952NDANDA008372Mallinckrodt Ireland
- Jun 16, 1954NDANDA008975Ani Pharms
FAERS reports
- 1Fatigue918.6%
- 2Drug Ineffective767.2%
- 3Multiple Sclerosis Relapse706.6%
- 4Headache656.2%
- 5Asthenia504.7%
- 6Condition Aggravated474.5%
- 7Malaise454.3%
- 8Pain413.9%
- 9Gait Disturbance403.8%
- 10Nausea403.8%
- 11Diarrhoea393.7%
- 12Fall393.7%
- 13Insomnia383.6%
- 14Dizziness373.5%
- 15Off Label Use373.5%
Literature
Recent PubMed references pinned to Corticotropin as a MeSH major topic. Citations link to pubmed.ncbi.nlm.nih.gov.
- ACTH independent Cushing's syndrome: Diagnosis and etiology.Vitamins and hormones · 2026 · Ortiz-Flores AEPMID 42236016DOI 10.1016/bs.vh.2026.02.001
- Differential diagnosis of ACTH-dependent Cushing's syndrome: Biochemical, imaging, and predictive approaches.Vitamins and hormones · 2026 · Rivera-Martínez WA, Builes-Montaño CE, Román-González A, et al.PMID 42236007DOI 10.1016/bs.vh.2026.03.002
- Avoiding false-positive adrenal insufficiency diagnoses in children: insights from cortisol kinetics during pediatric low-dose ACTH stimulation test.European journal of pediatrics · 2026 · Tepe D, Çetin SK, Gökdemir İ, et al.PMID 42228004DOI 10.1007/s00431-026-07129-5
- Adrenocorticotropin hormone regulates sphingosine-1-phosphate synthesis via cortisol in bovine adrenocortical cells.Biochemical and biophysical research communications · 2026 · Medina-Moctezuma ZB, Guzmán-Sánchez A, González-Aretia D, et al.PMID 42176386DOI 10.1016/j.bbrc.2026.153994
- Utility of the post-cosyntropin urinary metabolomic profile for the subtype diagnosis of primary aldosteronism.Journal of hypertension · 2026 · Araujo-Castro M, Hanzu FA, Goi J, et al.PMID 42160134DOI 10.1097/HJH.0000000000004329
- Daily administration of long-acting adrenocorticotropic hormone (ACTH) alters the developmental pattern of plasma fibrinogen in juvenile rats.Brain & development · 2026 · Takeda Y, Sakakibara T, Horiuchi K, et al.PMID 42114184DOI 10.1016/j.braindev.2026.104541
- Comparison of in vitro degradation of immunoreactive adrenocorticotropic hormone and insulin in equine blood measured by two immunoassay methods.Domestic animal endocrinology · 2026 · Durham AE, Gautam SS, Huber L, et al.PMID 42097040DOI 10.1016/j.domaniend.2026.107020
- Case report and literature review: isolated ACTH deficiency induced by combined nivolumab and trastuzumab therapy in gastric adenocarcinoma.Frontiers in endocrinology · 2026 · Shi L, Wang J, Xie X, et al.PMID 42087875DOI 10.3389/fendo.2026.1742701
Clinical trials
The 10 most recently updated of 221 ClinicalTrials.gov registrations naming Corticotropin as an intervention. Registration is not evidence of efficacy or safety — reference crosswalk only.
- Imaging CRF X NOP Interactions in CUDRecruiting · Early phase 1 · Interventional · 80 enrolled · Rajesh NarendranNCT05008146updated 2026-06-09
- CRF2 Agonist for the Treatment of Worsening Heart FailureActive not recruiting · Phase 2 · Interventional · 300 enrolled · Corteria PharmaceuticalsNCT06815471updated 2026-06-08
- FET PET/CT Imaging To Localize Pituitary Adenomas In Cushing DiseaseRecruiting · Early phase 1 · Interventional · 50 enrolled · Mayo ClinicNCT07460232updated 2026-05-29
- Combination Osilodrostat and Cabergoline in Cushing's DiseaseEnrolling by invitation · Phase 4 · Interventional · 50 enrolled · University of BasrahNCT07603466updated 2026-05-22
- A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate CancerRecruiting · Phase 2 · Interventional · 218 enrolled · Astellas Pharma Global Development, Inc.NCT07005154updated 2026-05-01
- Use of CXCL9 as a Biomarker of Acthar EfficacyTerminated · Phase 4 · Interventional · 2 enrolled · University of California, San FranciscoNCT02523092updated 2026-04-30
- Treatment of CNS Sarcoidosis With H.P. Acthar GelCompleted · Phase 4 · Interventional · 4 enrolled · University of Maryland, BaltimoreNCT02298491updated 2026-04-17
- Cardiorespiratory Fitness Training in Patients With Incomplete Spinal Cord InjuryTerminated · Interventional · 19 enrolled · Sint MaartenskliniekNCT06259227updated 2026-04-16
- Pharmacokinetic (PK), Pharmacodynamic (PD) and Tolerability of Osilodrostat in Pediatric Patients With Cushing's SyndromeRecruiting · Phase 2 · Interventional · 12 enrolled · RECORDATI GROUPNCT03708900updated 2026-03-27
- Use of Acthar in Patients With FSGS That Will be Undergoing Renal TransplantationCompleted · Phase 3 · Interventional · 15 enrolled · University of Colorado, DenverNCT02683889updated 2026-03-23
Frequently asked questions
- How does Corticotropin work?
- Mechanism-of-action class: Pituitary Hormone Receptor Agonists.
- What is Corticotropin used for?
- According to FDA labeling, Corticotropin carries indications including: USES TAKE 15 MINUTES BEFORE MEALS. This is a reference summary of labeled uses, not medical advice or a treatment recommendation.
- What class of drug is Corticotropin?
- Corticotropin is classified as ACTH, Adrenocorticotropic Hormone, Pituitary Hormone Receptor Agonists, Increased Glucocorticoid Secretion, Increased Mineralocorticoid Secretion.
- What are the brand names for Corticotropin?
- Corticotropin is marketed under brand names including Acthar, Cortrophin.
corticotropin is illustrative MVP content compiled from public sources. pharmacopeia is for educational and informational use only and is not a substitute for professional medical advice.